Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study.

Antimicrob Agents Chemother · 2017 · PMC5487684 · PMID 28507108

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

approaching significanceno p-value reported

3 ) and by a P value approaching significance (despite the low subject numbers), which was obtained for the longitudinal analysis of the viral load for this group.

also in 2,640 other papers

approached significanceno p-value reported

The mixed model analysis of the RNA load from day 2 to day 14 for this group approached significance, with P being equal to 0.096 (Table S2).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.